Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
•
Primary Care
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
Related Questions
How do you manage recurrent epistaxis from nasal steroids?
When do you consider lifelong AIT?
Have you observed adverse mental health side effects in patients who start montelukast?
Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?
Does splitting the dose of a vaccine during an observed administration affect the efficacy of the vaccine response?
Do you feel high dose Symbicort or Dulera is appropriate to use for SMART despite these doses not being studied in clinical trials?
What are your recommendations for managing perivascular dermatitis with eosinophils unresponsive to high-dose antihistamines, a prednisone taper, and topical steroids?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
What medications would you have a patient avoid with an IgE mediated reaction to cyclobenzaprine?
When initiating patients on Ragwitek, Odactra, and Grastek and the plan is to continue on all 3 tablets for the next 5 years instead of only for seasons, how far apart from each one do you give the initial dose?
